Dr. Jason Chesney, MD
Claim this profileUniversity of Louisville-James Graham Brown Cancer Center
Studies Melanoma
Studies Skin Cancer
6 reported clinical trials
7 drugs studied
Area of expertise
1Melanoma
Stage IV
BRAF positive
Stage III
2Skin Cancer
Stage IV
BRAF positive
MSI-H positive
Affiliated Hospitals
Clinical Trials Jason Chesney, MD is currently running
OBX-115
for Skin Cancer
This trial tests a new treatment called OBX-115 for adults with advanced solid tumors. It aims to see if the treatment is safe and effective by measuring its ability to shrink tumors, control disease progression, and improve survival.
Recruiting1 award Phase 1 & 211 criteria
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting1 award Phase 29 criteria
More about Jason Chesney, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jason Chesney, MD has experience with
- Nivolumab
- RP1
- Vemurafenib
- Metformin
- ITIL-168
- OBX-115
Breakdown of trials Jason Chesney, MD has run
Non-Small Cell Lung Cancer
Microsatellite Instability
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jason Chesney, MD specialize in?
Jason Chesney, MD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Jason Chesney, MD currently recruiting for clinical trials?
Yes, Jason Chesney, MD is currently recruiting for 5 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Jason Chesney, MD has studied deeply?
Yes, Jason Chesney, MD has studied treatments such as Nivolumab, RP1, Vemurafenib.
What is the best way to schedule an appointment with Jason Chesney, MD?
Apply for one of the trials that Jason Chesney, MD is conducting.
What is the office address of Jason Chesney, MD?
The office of Jason Chesney, MD is located at: University of Louisville-James Graham Brown Cancer Center, Louisville, Kentucky 40202 United States. This is the address for their practice at the University of Louisville-James Graham Brown Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.